Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: Behavioral and pharmacokinetic studies in mice

Pharmacology Biochemistry and Behavior

Volumn 81, Issue 3, 2005, Pages 524-529

  Poleszak, Ewa ^a   Wlaź, Piotr ^b   Szewczyk, Bernadeta ^c   Kȩdzierska, Ewa ^a   Wyska, Elzbieta ^d   Librowski, Tadeusz ^d   Szymura Oleksiak, Joanna ^d   Fidecka, Sylwia ^a   Pilc, Andrzej ^c,d   Nowak, Gabriel ^c,d  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^c INSTITUTE OF PHARMACOLOGY   (Poland)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Brain; Desipramine concentration; Forced swim test; Imipramine; Imipramine concentration; Magnesium; Magnesium concentration; Mice; Serum

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; IMIPRAMINE; MAGNESIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG POTENCY; FORCED SWIMMING TEST; HEMOCONCENTRATION; IMMOBILIZATION; LOCOMOTION; MAGNESIUM BLOOD LEVEL; MALE; METABOLITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TIME;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; IMIPRAMINE; MAGNESIUM; MALE; MICE; MOTOR ACTIVITY; STRESS, PSYCHOLOGICAL; SWIMMING; TIME FACTORS;

ANIMALIA;

EID: 22044435387     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.03.017     Document Type: Article

References (61)

1. N. Burnashev, R. Schoepfer, H. Monyer, J.P. Ruppersberg, W. Günther, and P.H. Seeburg Control by asparagines residues of calcium permeability and magnesium blockade in the NMDA receptor Science 257 1992 1415 1419
2. S. Decollogne, A. Tomas, C. Lecerf, E. Adamowicz, and M. Seman NMDA receptor complex blockade by oral administration of magnesium: comparison with MK-801 Pharmacol Biochem Behav 58 1997 261 268
3. W.J. Fawcett, E.J. Haxby, and D.A. Male Magnesium: physiology and pharmacology Br J Anaesth 83 1999 302 320
4. A. Frazer, T.A. Ramsey, A. Swann, C. Bowden, D. Brunswick, and D. Garver Plasma and erythrocyte electrolytes in affective disorders J Affect Disord 5 1983 103 113
5. D. Frizel, A. Coppen, and V. Marks Plasma magnesium and calcium in depression Br J Psychiatry 115 1969 1375 1377
6. R.D. Grubbs, and M.E. Maguire Magnesium as a regulatory cation: criteria and evaluation Magnesium 6 1987 113 127
7. R.C.W. Hall, and J.R. Joffe Hypomagnesemia: physical and psychiatric symptoms JAMA 224 1973 1751 1794
8. 2+: an endogenous modulator of ligand- and voltage-gated ion channels Neuropharmacology 33 1994 935 952
9. G.M. Hasey, E. D'Aleksandro, R.G. Cooke, and J.J. Warsh The interface between thyroid activity, magnesium, and depression: a pilot study Biol Psychiatry 33 1993 133 135
10. N. Hashizume, and M. Mori An analysis of hypermagnesemia and hypomagnesemia Jpn J Med 29 1990 368 372
11. J.G. Henrotte, G. Franck, M. Santarromana, H. Frances, D. Mouton, and R. Motta Mice selected for low and high blood magnesium levels: a new model of stress studies Physiol Behav 61 1997 653 658
12. L.E. Hollister, and J.G. Csernansky Clinical Pharmacology of Psychotherapeutic Drugs 3rd ed. 1990 Churchill Livingstone New York
13. A. Hulanicki Magnesium: chemical properties and methods of determination Clin Chem Enzymol Commun 5 1993 135 142
14. S. Iannello, and F. Belfiore Hypomagnesemia. A review of pathophysiological, clinical and therapeutical aspects Panminerva Med 43 2001 177 209
15. S. Johnson The multifaceted and widespread pathology of magnesium deficiency Med Hypotheses 56 2001 163 170
16. K. Kamei, O. Tabata, S.I. Muneoka, R. Tomiyoshi, and M. Takigawa Electrolytes in erythrocytes of patients with depressive disorders Psychiatry Clin Neurosci 52 1998 529 533
17. K.M. Kantak Magnesium deficiency alters aggressive behavior and catecholamine function Behav Neurosci 102 1988 304 311
18. A. Kemeny, H. Boldizsar, and G. Pethes The distribution of cations in plasma and cerebrospinal fluid following infusion of solutions of salts of sodium, potassium, magnesium, and calcium J Neurochem 7 1961 218 227
19. D.K. Kirov, N.J. Birch, P. Steadman, and R.G. Ramsey Plasma magnesium levels in a populations of psychiatric patients: correlations with symptoms Neurobiology 30 1994 73 78
20. B. Kroczka, A. Ziȩba, D. Dudek, A. Pilc, and G. Nowak Zinc exhibits an antidepressant-like effects in the forced swimming test in mice Pol J Pharmacol 52 2000 403 406
21. B. Kroczka, P. Branski, A. Palucha, A. Pilc, and G. Nowak Antidepressant-like properties of zinc in rodent forced swim test Brain Res Bull 55 2001 297 300
22. R.T. Layer, P. Popik, T. Olds, and P. Skolnick Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715) Pharmacol Biochem Behav 52 1995 621 627
23. J. Linder, K. Brismar, J. Beck-Friss, J. Saaf, and L. Wetterberg Calcium and magnesium concentration in affective disorder: difference between plasma and serum in relation to symptoms Acta Psychiatr Scand 80 1989 527 537
24. M. Maes, E. Vandoolaeghe, H. Neels, P. Demedts, A. Wauters, and H.Y. Meltzer Lower serum zinc in major depression in a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness Biol Psychiatry 42 1997 349 358
25. J. Maj, Z. Rogóż, G. Skuza, and H. Sowińska The effect of CGP37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test Pol J Pharmacol 44 1992 337 346
26. J. Maj, Z. Rogóż, G. Skuza, and H. Sowińska Effects of MK-801 and antidepressant drugs in the forced swimming testing rats Eur Neuropsychopharmacol 2 1992 37 41
27. 2+-block site of the NMDA receptor channel Nature 358 1992 673 675
28. M.E. Morris Brain and CSF magnesium concentrations during magnesium deficit in animals and humans: neurological symptoms Magnes Res 5 1992 303 313
29. H. Murck Magnesium and affective disorders Nutr Neurosci 5 2002 375 389
30. G. Nowak, and B. Szewczyk Mechanisms contributing to antidepressant zinc actions Pol J Pharmacol 2002 587 592
31. G. Nowak, R. Trullas, R.T. Layer, P. Skolnick, and I.A. Paul Adaptive changes in the N-methyl-d-aspartate receptor complex after chronic treatment with imipramine and 1-amino-cyclopropnecarboxylic acid J Pharmacol Exp Ther 265 1993 1380 1386
32. G. Nowak, A. Redmond, M. McNamara, and I.A. Paul Swim stress increases the potency of glycine at the N-methyl-d-aspartate receptor complex J Neurochem 64 1995 925 927
33. G. Nowak, B. Legutko, P. Skolnick, and P. Popik Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors Eur J Pharmacol 342 1998 367 370
34. G. Nowak, A. Ziȩba, D. Dudek, M. Krośniak, M. Szymaczek, and M. Schlegel-Zawadzka Serum trace elements in animal models and human depression: Part I. Zinc Hum Psychopharmacol Clin Exp 14 1999 83 86
35. G. Nowak, B. Szewczyk, J.M. Wieronska, P. Branski, A. Palucha, and A. Pilc Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats Brain Res Bull 61 2003 159 164
36. L. Novak, P. Bregestowski, P. Acher, A. Herbert, and A. Prochiantz Magnesium gates glutamate-activated channels in mouse central neurons Nature 307 1984 462 465
37. W.W. Oppelt, I. MacInyre, and D.P. Rall Magnesium exchange between blood and cerebrospinal fluid Am J Physiol 205 1963 959 962
38. M. Papp, and E. Moryl Antidepressant activity of non-competitive and competitive NMDA receptor antagonist in a chronic mild stress model of depression Eur J Pharmacol 263 1994 1 7
39. M. Papp, and E. Moryl Antidepressant-like effects of I- aminocyclopropanecarboxylic acid and d-cycloserine in an animal model of depression Eur J Pharmacol 316 1996 145 151
40. I.A. Paul, G. Nowak, R.T. Layer, P. Popik, and P. Skolnick Adaptation of N-methyl-d-aspartate receptor complex following chronic antidepressant treatments J Pharmacol Exp Ther 269 1994 95 102
41. D. Pavlinac, R. Langer, L. Lenhard, and L. Deftos Magnesium in affective disorders Biol Psychiatry 14 1979 657 661
42. A. Pilc, A. Kłodzińska, and G. Nowak A role for glutamate in the treatment of anxiety and depression: focus on group I metabotropic glutamate (mGlu) receptors Drugs Future 27 2002 753 763
43. E. Poleszak, B. Szewczyk, E. Kȩdzierska, P. Wlaź, A. Pilc, and G. Nowak Antidepressant- and anxiolytic-like activity of magnesium in mice Pharmacol Biochem Behav 78 2004 7 12
44. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice: a primary screening test for antidepressants Arch Int Pharmacodyn Ther 229 1977 327 336
45. A.S. Prasad Biochemistry of zinc 1993 Plenum Press New York
46. H.H. Rasmussen, P.B. Mortensen, and I.W. Jensen Depression and magnesium deficiency Int J Psychiatry Med 19 1989 57 63
47. M.F. Ryan The role of magnesium in clinical biochemistry: an overview Ann Clin Biochem 28 1991 19 26
48. N.E.L. Saris, E. Mervaala, H. Karppanen, J.A. Khawaja, and A. Lewenstam Magnesium, an update on physiological, clinical and analytical aspects Clin Chim Acta 294 2000 1 26
49. R.J. Schain Cerebrospinal fluid serum cation levels Arch Neurol 11 1964 330 333
50. P. Skolnick Antidepressants for the new millennium Eur J Pharmacol 375 1999 31 40
51. P. Skolnick, R.T. Layer, P. Popik, G. Nowak, I.A. Paul, and R. Trullas Adaptation of N-methyl-d-aspartate receptors following antidepressant treatment: implications for the pharmacotherapy of depression Pharmacopsychiatry 29 1996 23 26
52. P. Skolnick, B. Legutko, X. Li, and F.P. Bymaster Current perspectives on the development of non-biogenic amine-based antidepressants Pharmacol Res 43 2001 411 422
53. A.I. Sobolevskii, and B.I. Khodorov Blocker studies of the functional architecture of the NMDA receptor channel Neurosci Behav Physiol 32 2002 157 171
54. S.M. Stahl Psychopharmacology of antidepressants 1997 Martin Duinz London
55. B. Szewczyk, P. Brański, J.M. Wieroñska, A. Pałucha, A. Pilc, and G. Nowak Interaction of zinc with antidepressants in the forced swimming test in mice Pol J Pharmacol 54 2002 681 685
56. J. Szymura-Oleksiak, E. Wyska, and A. Wasieczko Pharmacokinetic interaction between imipramine and carbamazepine in patients with major depression Psychopharmacology 154 2001 38 42
57. R. Trullas, and P. Skolnick Functional antagonists at the NMDA receptor complex exhibit antidepressant action Eur J Pharmacol 185 1990 1 10
58. W.B. Vermon The role of magnesium in nucleic acid and protein metabolism Magnesium 7 1998 234 248
59. J. Widmer, P. Bovier, F. Karege, Y. Raffin, H. Hildret, and J.M. Gaillard Evolution of blood magnesium, sodium and potassium in depressed patients followed for three months Neuropsychopharmacology 26 1992 173 179
60. J. Widmer, J.G. Henrotte, Y. Raffin, P. Bovier, H. Hillert, and J.M. Gaillard Relationship between erythrocyte magnesium, plasma electrolytes and cortisol and intensity of symptoms in major depressed patients J Affect Disord 34 1995 201 209
61. A. Ziȩba, R. Kata, D. Dudek, M. Schlegel-Zawadzka, and G. Nowak Serum trace elements in animal models and human depression: Part III. Magnesium, relationship with copper Hum Psychopharmacol Clin Exp 15 2000 631 635